Autopsy report · NCT03982992

Allogeneic Donor Lymphocyte Infusions Combined With Blinatumomab

“Lack of potential study subjects due to a change of standard of care treatment outside of clinical trials.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

Ludwig-Maximilians - University of Munich

Sponsor type

University, hospital or other

Conditions

B Cell Precursor Acute Lymphoblastic Leukemia With Mixed Chimerism or Minimal Residual Disease After Allogeneic Stem Cell Transplantation; B-Cell Acute Lymphoblastic Leukemia; Acute Lymphoblastic Leukemia; Acute Lymphoblastic Leukemia in Remission; Acute Lymphoblastic Leukemia, Adult

Interventions

Blinatumomab in combination with donor lymphocyte infusion

Participants

0

Sites

1

Countries

Germany

Trials that died the same way

• Convalescent Plasma as Treatment for Hospitalized Subjects With COVID-19 Infection
  “Lack of eligible patients due to change in standard therapy” (72% match in meaning)
• Antiepileptic Drugs and Vascular Risk Markers
  “study no longer consistent with current clinical practice” (68% match in meaning)
• Efficacy of the Infusion of Donor Plasma in COVID-19 Infection
  “Lack of efficacy of treatment tested” (66% match in meaning)
• The CONNECT Program: Testing a Telephone-Based Mental Health Intervention for Older Adults
  “Change in study design was implemented and the study design no longer follows a pilot randomized controlled trial.” (64% match in meaning)
• Brachytherapy Radiation Directly to the Liver in Breast Cancer Patients With Metastatic to Liver
  “Lack of study patients” (63% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.